Rybelsus 7 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5RCT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,392
Award facts
- Contract value 100% obligated
- $31,391.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,391.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Rybelsus 7 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with a completion date of January 30, 2026, and performance will be completed at the contractor's facility in Conshohocken, Pennsylvania. The order is issued under the parent company Cencora, Inc.'s (doing business as AmerisourceBergen) significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. As a child entity of Cencora, Inc., AmerisourceBergen maintains an extensive portfolio of pharmaceutical deliveries through the DLA Medical Supply Chain, consistently meeting federal procurement requirements through competitive awards. The Rybelsus delivery order represents a routine pharmaceutical procurement supporting military treatment facilities and Defense Health Agency operations, contributing to the broader pharmaceutical supply chain that encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F5RCT?
SPE2DR26F5RCT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F5RCT worth?
The government has obligated $31,392 on SPE2DR26F5RCT.
Is contract SPE2DR26F5RCT an order under another contract?
Yes. SPE2DR26F5RCT is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5RCT competed?
The extent of competition for SPE2DR26F5RCT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award